Clinical significance of nuclear localisation of agrin in lung adenocarcinoma.
暂无分享,去创建一个
Dong Li | Hongwei Li | Q. Shen | Zhonghai Xie | Q. Gu
[1] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[2] Flávia S. Zandonadi,et al. Agrin has a pathological role in the progression of oral cancer , 2018, British Journal of Cancer.
[3] S. Ye,et al. Different molecular subtypes of breast invasive ductal carcinoma. , 2018, Journal of biological regulators and homeostatic agents.
[4] Y. Li,et al. Comparison of gefitinib and platinum-based chemotherapy and only platinum-based chemotherapy to treat lung adenocarcinoma. , 2018, Journal of biological regulators and homeostatic agents.
[5] C. Lim,et al. Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway. , 2017, Cell reports.
[6] S. Anker,et al. Evaluation of C‐terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation , 2015, Journal of cachexia, sarcopenia and muscle.
[7] R. Iozzo,et al. Decoding the Matrix: Instructive Roles of Proteoglycan Receptors. , 2015, Biochemistry.
[8] W. Hong,et al. An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma , 2015, Nature Communications.
[9] F. Fonseca,et al. Agrin and Perlecan Mediate Tumorigenic Processes in Oral Squamous Cell Carcinoma , 2014, PloS one.
[10] Andrea I. McClatchey,et al. Spatial regulation of receptor tyrosine kinases in development and cancer , 2012, Nature Reviews Cancer.
[11] M. Waters,et al. The growth hormone receptor: mechanism of activation and clinical implications , 2010, Nature Reviews Endocrinology.
[12] W. Schmiegel,et al. Immunoscreening of the extracellular proteome of colorectal cancer cells , 2010, BMC Cancer.
[13] L. Mei,et al. LRP4 Serves as a Coreceptor of Agrin , 2008, Neuron.
[14] S. Hubbard,et al. Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK , 2008, Cell.
[15] I. Kovalszky,et al. Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma. , 2007, Human pathology.
[16] M. Waters,et al. Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis , 2007, Proceedings of the National Academy of Sciences.
[17] J. Krolewski. Cytokine and growth factor receptors in the nucleus: What's up with that? , 2005, Journal of cellular biochemistry.
[18] G. Sozzi. Molecular biology of lung cancer. , 2001, European journal of cancer.
[19] M. Chevallier,et al. Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas , 2000, Endocrine.
[20] M. Waters,et al. Cellular expression of growth hormone and prolactin receptors in human breast disorders , 1998, International journal of cancer.
[21] J. Sanes,et al. Defective Neuromuscular Synaptogenesis in Agrin-Deficient Mutant Mice , 1996, Cell.
[22] Y. Huang,et al. Relationship between methylation status of RASSF2A gene promoter and endometriosis-associated ovarian cancer. , 2018, Journal of biological regulators and homeostatic agents.
[23] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[24] Liquid Biopsies. Non-small-cell lung cancer , 2015, Nature Reviews Disease Primers.
[25] M. Waters,et al. Growth hormone and colorectal carcinoma: localization of receptors. , 2000, In vivo.
[26] M. Waters,et al. Up-regulation of growth hormone receptor immunoreactivity in human melanoma. , 1999, Anticancer research.
[27] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.